Abstract
In Japan, the revision of the Copyright Act and the Unfair Competition Prevention Act has been made toward the use of artificial intelligence (AI) and data. The Ministry of Economy, Trade, and Industry have issued "Contract guidelines on the use of AI data" and other rules are being developed. In the medical field, in addition to these general rules, it is important to protect patient rights and to protect intellectual property for appropriate evaluation of medical personnel for data creation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
